Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M370Revenue (TTM) $M124Net Margin (%)-18.2Altman Z-Score-9.1
Enterprise Value $M345EPS (TTM) $-0.1Operating Margin %-13.8Piotroski F-Score3
P/E(ttm)--Beneish M-Score0.5Pre-tax Margin (%)-18.5Higher ROA y-yY
Price/Book8.110-y EBITDA Growth Rate %-33.9Quick Ratio1.8Cash flow > EarningsN
Price/Sales2.65-y EBITDA Growth Rate %-30.0Current Ratio1.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-10.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-76.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M253ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with ARNA

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ARNA is held by these investors:



ARNA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
White Christine AnnaDirector 2016-06-13Sell18,728$1.99-34.67view
WOODS RANDALL EDirector 2015-03-30Sell76,268$4.49-71.05view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-03-17Sell70,000$5-74view
SPECTOR STEVEN WEVP, General Counsel & Sec 2015-01-08Sell45,000$6.26-79.23view
SHANAHAN WILLIAM R JRSVP & Chief Medical Officer 2015-01-07Sell50,000$5.49-76.32view
LIEF JACKChairman, President and CEO 2014-07-01Sell223,525$5.85-77.78view
BELCHER DONALD DDirector 2014-06-27Sell2,473$5.85-77.78view
SPECTOR STEVEN WEVP, General Counsel & Sec 2014-05-12Sell45,000$7.05-81.56view
BELCHER DONALD DDirector 2014-05-06Sell4,176$7-81.43view
HIXSON HARRY F JRDirector 2014-04-22Sell36,900$6.31-79.4view

Press Releases about ARNA :

Quarterly/Annual Reports about ARNA:

News about ARNA:

Articles On GuruFocus.com
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full o Apr 21 2017 
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock Apr 17 2017 
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock Apr 17 2017 
Arena Pharmaceuticals Announces Multiple Presentations at ASPET 2017 at Experimental Biology Apr 17 2017 
Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter and Full-Year 2016 Fina Mar 06 2017 
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
(ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial Results Nov 16 2013 
WEEKLY CFO SELLS HIGHLIGHT: ZNGA, ARNA, JACK, TUMI, PANW Apr 07 2013 
WEEKLY CFO SELLS HIGHLIGHT: QCOM, RA, ARNA, ATU, DGX, MSCC Oct 07 2012 
Arena Facing Increased Pressure from Peers Apr 23 2012 

More From Other Websites
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full... Apr 21 2017
Arena Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ARNA) : April 19, 2017 Apr 19 2017
Arena Pharma (ARNA) Down After Underwritten Public Offering Apr 19 2017
Biotech Industry Outperforming Major Indexes in 2017: Today's Research Reports on Arena... Apr 19 2017
Why Is Arena Pharmaceuticals (ARNA) Down 11.3% Since the Last Earnings Report? Apr 19 2017
Arena Takes a Beating After Lackluster Secondary, Cytokinetics Pops: Biotech Movers Apr 18 2017
Why Arena Pharmaceuticals Stock Is Getting Hammered Today Apr 18 2017
Arena Pharmaceuticals Sinks After Announcing Secondary Offering Apr 18 2017
Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARNA-US : April... Apr 18 2017
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock Apr 17 2017
Arena Pharmaceuticals Announces Multiple Presentations at ASPET 2017 at Experimental Biology Apr 17 2017
The State of Play in Axovant Sciences Apr 11 2017
Why Arena Pharmaceuticals Stock Slimmed Down in March Apr 10 2017
ETFs with exposure to Arena Pharmaceuticals, Inc. : April 7, 2017 Apr 07 2017
New Strong Sell Stocks for April 6th Apr 06 2017
Today's Research Reports on Biotech Stocks to Watch: Arena Pharmaceuticals and Immunomedics Mar 28 2017
Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARNA-US : March... Mar 28 2017
ETFs with exposure to Arena Pharmaceuticals, Inc. : March 27, 2017 Mar 27 2017
Arena Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference on April 4th Mar 27 2017
Arena Pharmaceuticals, Inc. :ARNA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)